• Search
  • Helpdesk
  • Sales contact
  • OncologyOncology studies present specific challenges that generate complex eCOA build and management: complex study design, frequent amendments, and long study duration that can affect patient engagement and site organization.

“Oncology clinical trials are particularly complex for patients and sites suffering from long study duration. Patient compliance can be affected by adverse events & perception of study burden over time, while protocols may be amended with additional visits, inclusion/exclusion criteria modification, or additional safety procedures.“

Patient advocate XXXX

Streamlining Complex Oncology Trials with Expert Solutions

Kayentis tackles the challenges of oncology clinical trials thanks to an extensive experience in complex situations:

Check our latest insights about Oncology trials

Cultural differences and individual preferences have a significant impact on healthcare and clinical trial experience. Solutions exist in attempt

Long study duration can have a negative impact on patient compliance As for any clinical trial, poor compliance in

The oncology research pathway is paved with numerous challenges, and oncology clinical trials have one of the lowest success

Our therapeutic areas

Oncology
Learn more
Immunology-Inflammatory
Learn more
Rare disease
Learn more
Cardiology
Learn more
Gastroenterology
Learn more
Respiratory
Learn more
Dermatology
Learn more
Ophthalmology
Learn more
Metabolic health
Metabolic health
Learn more
Pediatric
Learn more